Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
18
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 23 publications
(18 citation statements)
references
References 37 publications
0
18
0
Order By: Relevance
“…A total of 13 studies reported in-hospital mortality (32,33,35,(39)(40)(41)(42)(45)(46)(47)(48)50,52), all of which reported no significant difference between the 2 groups. There were 11 deaths (0.4%) in the ERAS group and 28 deaths (0.7%) in the control group.…”
Section: In-hospital Mortalitymentioning
confidence: 99%
See 1 more Smart Citation
“…A total of 13 studies reported in-hospital mortality (32,33,35,(39)(40)(41)(42)(45)(46)(47)(48)50,52), all of which reported no significant difference between the 2 groups. There were 11 deaths (0.4%) in the ERAS group and 28 deaths (0.7%) in the control group.…”
Section: In-hospital Mortalitymentioning
confidence: 99%
“…In order to assess the effects of ERAS programs on postoperative complications in detail, we performed a subgroup analysis as follows: pulmonary complications, cardiovascular complications, urinary complications, and surgical complications. (32,33,37,39,42,45,48,52), and 8 in the subgroup of surgical complications (33,(37)(38)(39)(43)(44)(45)52).…”
Section: Subgroup Analysismentioning
confidence: 99%
“…The ERAS pathway has been associated with effective postoperative analgesia, major reductions in inhospital opioids consumption, and reduced pain, relative to conventional management practices. 170 Moreover, preoperative multimodal exercise and nutritional programs (prehabilitation) are associated with improved 5-year disease free survival in stage III colorectal cancer after surgical resection. 171 In colorectal cancer patients, application of the ERAS protocol is associated with low inflammatory metrics on postoperative day 1, and improved 5-year survival after surgery.…”
Section: Inhibition Of Mdsc-mediated Immunosuppressionmentioning
confidence: 99%
“…While the components of ERATS work synergistically to provide the most optimal outcomes, effective thoracic pain control with an opioid-sparing strategy, coupled with posterior intercostal nerve blocks and surgical wound infiltration with long-acting local anesthetic preparation liposomal bupivacaine, plays an essential role. Since the initial reports by Rice and Mehran of the MD Anderson Cancer Center (9,10) that described and popularized this technique within the context of ERATS, many medical centers, including our own, have described successful implementation of ERATS with significant improvement of a wide range of outcome metrics such as reduced pain and opioid requirements, postoperative complications, and postoperative hospital length of stay (LOS) (1,2,(11)(12)(13).…”
Section: Introductionmentioning
confidence: 99%
“…Reduction of postoperative pain and opioid requirements in thoracic patients has been associated with decreased postoperative complications, particularly cardiopulmonary complications, and decreased hospital LOS in those undergoing thoracotomies for pulmonary resections (1,2,11,12). It has been argued that MITS, in and of itself, is a component of ERATS (5) and it is hard to improve already optimal outcome metrics such as postoperative LOS of MITS.…”
Section: Introductionmentioning
confidence: 99%